Abeba Demelash Ph.D. Email & Phone Number
area 240
LinkedIn matched
Who is Abeba Demelash Ph.D.? Overview
A concise factual answer block for searchers comparing this professional profile.
Abeba Demelash Ph.D. is listed as Senior Scientist I at Merck, based in San Francisco, California, United States. AeroLeads shows phone signal with area code 240 and a matched LinkedIn profile for Abeba Demelash Ph.D..
Abeba Demelash Ph.D. previously worked as Sr Scientist at Merck and Senior Scientist I at Ambys Medicines. Abeba Demelash Ph.D. holds Ph.D. At Sahlgrenska University Hospital, Cell And Molecular Biology from University Of Gothenburg.
Email format at Merck
This section adds company-level context without repeating Abeba Demelash Ph.D.'s masked contact details.
Review company-level records connected to Abeba Demelash Ph.D. before choosing the right outreach path.
About Abeba Demelash Ph.D.
Innovative and solutions-oriented scientist with broad scientific knowledge, 14 + years of industry and academia experience in the area of translational oncology and histopathology research. Hands-on experience in studying mechanisms of cancer progression in multiple cancer types. Skilled and expertise in molecular biology, biomarker assay, targeted cancer therapeutics, method developments, animal tissue-based research using novel RNA-ISH technologies, histological stains, whole slide scanning, reviewing of microscopic slides and image analyses. Taking projects from idea to actual data in a presentation-ready format. Great ability to establish and cultivate collaborations with research teams, external contract research organization (CRO) and pathologists. Excellent project manager as evidenced by leading several cancer research, cell therapy, and gene therapy projects.As a biomedical and cancer research scientist, my passion is to translate basic science discoveries into therapeutics and bringing new products applications to the market to improve the lives of patients. Let's connect: demelash.abeba@gmail.com.
Listed skills include Molecular And Cellular Biology, Cancer Biology, Mouse Models, Cell Culture, and 44 others.
Abeba Demelash Ph.D.'s current company
Company context helps verify the profile and gives searchers a useful next step.
Abeba Demelash Ph.D. work experience
A career timeline built from the work history available for this profile.
Sr Scientist
Current
Senior Scientist I
Current
Scientist Ii, Cell Therapy Team
Associate Scientist, Cell/Gene Therapy Team
Council Member
• Served as a council member who can consult on projects associated with the molecular diagnostic test for cancer research and histopathological platforms • Provided guidance and direction on biochemical, molecular and cellular biology study design to inform investment decisions• Advised clients on establishing appropriate research methodologies, resources and pricing to optimize profitability and meet business goals
Research Scientist, Oncology, Clinical Cell-Based Assay, Project Management Multiplex If/Ihc.
• Led hypothesis-driven, chemotherapy resistance study. In this role, I was able to demonstrate strategic thinking by formulating research questions and link them to study designs to explore targetable molecules and their pathways in colon, melanoma and head & neck cancer, which led to a proposal and submission of over $ 1.25 million in NIH RO1 grant funding.• I have managed multiple projects with excellent project management and problem-solving skills. In this role, I was responsible for R&D sponsored projects (AbbVie oncology unite); developed and optimized IHC protocol and completed a systematic analysis of therapeutic bio-markers in more than 190 primary and metastatic colorectal cancer patient samples. • Evaluated potential therapeutic targets and their signaling pathways associated with the anti-tumor activity of small molecule drugs by using cell viability, proliferation, DNA damage, oxidative stress, senescence, apoptosis response on drug-sensitive and -resistance cancer cell lines.• Completed immunological staining of therapeutic targets in 20 melanoma, 27 head and neck squamous cell carcinoma HNSCC patient tissues.• Independently organized and maintained a molecular biology laboratory for over 2 years including monitoring chemicals, reagents, cleanliness, documentation; maintained budgets and negotiated supply costs; ensured the implementation of GLP, SOP regulations.• Collaborated with multidisciplinary teams, including pharmaceutical companies, clinicians and research scientist groups in a fast-paced research environment, contributed on a key project defining how cancer stem cell drive triple-negative breast cancer published on the scientific journal Nature Communication • Demonstrated excellent technical and problem‐solving skills by developing high throughput biochemical, molecular and cellular assays for the study of animal diseases ranging from genotyping to tissue pathological analysis.
Research Scientist, Cancer (Post-Doc), Biomarker Assay, Target Identification, Data Analsis.
PROJECT: Exploring the molecular pathology of lung carcinogenesis and differentiation.• Identified a novel mechanism of the CDK5, P35, and HASH cell signaling pathways in the initiation and progression of non-small cell lung cancer (NSCLC), leading to 2 peer-reviewed publications• Conceived and performed exploratory mouse model studies, including crossing and maintaining 6 colonies of transgenic mice, genotyping, injections, dissection, tissue processing, molecular histology of mouse diseases, immunohistochemistry, Laser capture microdissection (LCM), and data analysis• Worked in a dedicated and focused manner, preparing of 100 mouse DNA samples for genotyping in a week, performing of necropsies and tissue collection from 40 mice in a week, and stained 60 slides for histological diagnosis per week • Conceived and performed biochemical, molecular and cellular biology techniques including transfection, kinase assay, qPCR, migration, wound healing, immunofluorescence, co-immunoprecipitation to explore HASH signaling pathway responsible for the progression of lung cancer in vitro. • Effectively managed and controlled project budgets for 4 years
Research Scientist, Cell Signaling Pathway.
• Developed study design and conducted cell-based assays for data collection, accomplished several molecular and biochemical research objectives that define apoptotic signaling pathways in thyroid primary cells, neuronal cell differentiation/proliferation.• Technical expertise: Cell-based assays; primary cell culture; DNA and RNA Isolation and purification; DNA fragmentation; Western blotting; SDS-Page; Immunofluorescence; Confocal microscopy; Fluorescence microscopy; measuring trans-epithelial resistance; Mitochondrial morphology; Cytotoxicity (CellTiterGlo, LDH and MTT).
Ph.D. Research Scientist
PROJECT: Understanding the apoptosis signaling pathway induced by oxidative stress and drugs in thyroid epithelial cells. The discoveries made in this project resulted in several awards and travel grants and 1 first authored peer-reviewed publication. Dissertation ISBN: 91-628-6249-9, Regulation of Apoptosis in the Thyroid Epithelium.• Skillfully performed cell-based assays using different approaches such as protein/DNA/RNA extractions, western blotting, cellular enzyme activity, and trans-epithelial electrical resistance measurements, immunofluorescent.• Developed study design and methods of data collection and analysis. Maintained detailed experimental records and laboratory notebook. • Presented weekly project progress reports at internal and external meetings, oral and poster presentations at national and international scientific meetings. Developed a genuine interest in and passion for oncology.
Abeba Demelash Ph.D. education
Ph.D. At Sahlgrenska University Hospital, Cell And Molecular Biology
Master'S Degree, Cellular And Molecular Biology
Bachelor'S Degree, Cell Biology
Frequently asked questions about Abeba Demelash Ph.D.
Quick answers generated from the profile data available on this page.
What company does Abeba Demelash Ph.D. work for?
Abeba Demelash Ph.D. works for Merck.
What is Abeba Demelash Ph.D.'s role at Merck?
Abeba Demelash Ph.D. is listed as Senior Scientist I at Merck.
What is Abeba Demelash Ph.D.'s phone number?
AeroLeads has found 1 phone signal(s) with area code 240 for Abeba Demelash Ph.D. at Merck.
Where is Abeba Demelash Ph.D. based?
Abeba Demelash Ph.D. is based in San Francisco, California, United States while working with Merck.
What companies has Abeba Demelash Ph.D. worked for?
Abeba Demelash Ph.D. has worked for Merck, Ambys Medicines, Glg (Gerson Lehrman Group), The Cleveland Clinic Foundation, Lerner Research Institute, and National Institutes Of Health, National Cancer Institute (Nih/Nci)..
How can I contact Abeba Demelash Ph.D.?
You can use AeroLeads to view verified contact signals for Abeba Demelash Ph.D. at Merck, including work email, phone, and LinkedIn data when available.
What schools did Abeba Demelash Ph.D. attend?
Abeba Demelash Ph.D. holds Ph.D. At Sahlgrenska University Hospital, Cell And Molecular Biology from University Of Gothenburg.
What skills is Abeba Demelash Ph.D. known for?
Abeba Demelash Ph.D. is listed with skills including Molecular And Cellular Biology, Cancer Biology, Mouse Models, Cell Culture, Protein Expression, Western Blotting, Transfection, and Qpcr.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial